Knowledge Base Retrieval and Recall for siRNA Nucleic Acid

Data Characteristics in this Category

siRNA nucleic acid drug clinical trial data primarily comes from clinical trial registries (e.g., ClinicalTrials.gov, WHO ICTRP), pharmaceutical company internal research reports, academic journal articles, and patent databases. This data typically exists as a mix of structured and unstructured documents. Structured data includes key information from trial protocols (e.g., drug name, target, indication, administration route, dosage, subject inclusion/exclusion criteria, primary/secondary endpoints), often presented in tables or predefined fields. Unstructured data contains detailed trial descriptions, safety reports, pharmacokinetic/pharmacodynamic data, statistical analysis plans and results, mostly in PDF, Word, or plain text formats. Data updates frequently, with new clinical trial registrations, trial result publications, and regulatory review opinions continuously generating new information. Documents often contain specific biological and pharmaceutical terminology, such as siRNA sequences, target gene mRNA, IC50 values, EC50 values, PK/PD parameters, and adverse event AE grading.

Constraints Imposed by these Characteristics on "Knowledge Base Retrieval and Recall"

The specificity of siRNA nucleic acid drugs lies in their sequence specificity, target diversity, and complex delivery systems. This requires the knowledge base to accurately identify and associate these key pieces of information during retrieval, for example, an siRNA sequence with multiple potential targets, or the impact of different delivery methods on efficacy and safety. The mixture of structured and unstructured data means integrating multiple processing strategies. Numerical information in trial protocols, such as dosage and frequency, requires support for range queries or unit conversions during retrieval, for example, nM to μM. High update frequency demands an efficient incremental update mechanism for the knowledge base to ensure the timeliness of retrieval results. The dense occurrence of specialized terminology places high demands on the domain adaptability of tokenizers and embedding models, requiring avoidance of recall bias due to inaccurate identification of specialized vocabulary. The sparse distribution of key information in long documents also requires effective segmentation strategies to capture context, preventing key information from being truncated or lost.

Configuration Settings

Configuration Item	Recommended Value	Rationale
`Chunk Length`	`500–800 characters`	Balances the integrity of long sentences and paragraphs in siRNA trial reports, preventing key information truncation.
`Chunk Overlap`	`100 characters`	Ensures contextual continuity between adjacent paragraphs, especially when describing complex pharmacokinetic curves or adverse events.
`Recall Count`	`8–12 chunks`	Covers a sufficient number of relevant clinical trial details, particularly comparisons involving different dose groups or targets.
`Similarity Threshold`	`0.75–0.85`	Balances recall and precision, filtering highly relevant document segments for siRNA trial protocols, avoiding interference from irrelevant information.
`Rerank Count`	`5 chunks`	Further refines initial recall results using a reranking model, prioritizing the most matching trial data.
`Max Concurrent Files`	`5`	Adapts to the large volume and complex charts typical of clinical trial documents, preventing system blockage due to excessively long processing times for a single file.

Three Common Pitfalls

Knowledge base retrieval results contain a large amount of irrelevant or low-relevance clinical trial data. This manifests as generally low similarity scores or summaries returned that are far from the query intent. This is due to overly coarse chunking strategies that fail to effectively split independent information blocks within long documents, leading to inaccurate embedding representations.
Uploading large PDF clinical trial reports results in the system being unresponsive for extended periods or an error PARSE_FILE_TIMEOUT_SECONDS. This typically occurs because the file parser is not optimized for such complex documents, leading to inefficient processing of PDF files containing numerous tables, images, or complex layouts.
Queries for specific siRNA sequences or target names fail to reflect their sequence specificity or target association in the recall results. This may be due to a lack of pre-training or fine-tuning for biomedical domain-specific vocabulary, preventing the word embedding model from accurately capturing these highly specialized entity relationships.

How to Verify Configuration

Select a batch of typical queries, such as those for dose-escalation trials or adverse event rates of specific siRNA drugs. Observe the recall count and similarity score to evaluate the coverage and precision of the recall results.
Submit clinical trial PDF documents containing complex tables and multiple figures. Check if the knowledge base successfully parses and generates text chunks suitable for retrieval, verifying the stability of file processing.
For queries containing biomedical professional terms like siRNA sequences, target gene names, and IC50 values, verify if the context of these terms in the recall results matches and confirm if related numerical information is correctly extracted.

Note: The values provided are common starting points and should be measured against your own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.